Advisors Asset Management, Inc. Tg Therapeutics, Inc. Transaction History
Advisors Asset Management, Inc.
- $5.28 Billion
- Q3 2024
A detailed history of Advisors Asset Management, Inc. transactions in Tg Therapeutics, Inc. stock. As of the latest transaction made, Advisors Asset Management, Inc. holds 6,978 shares of TGTX stock, worth $210,037. This represents 0.0% of its overall portfolio holdings.
Number of Shares
6,978
Previous 6,978
-0.0%
Holding current value
$210,037
Previous $124,000
31.45%
% of portfolio
0.0%
Previous 0.0%
Shares
4 transactions
Others Institutions Holding TGTX
# of Institutions
338Shares Held
87.7MCall Options Held
2.35MPut Options Held
1.7M-
Vanguard Group Inc Valley Forge, PA15.4MShares$463 Million0.01% of portfolio
-
Black Rock Inc. New York, NY11.4MShares$343 Million0.0% of portfolio
-
State Street Corp Boston, MA9.09MShares$274 Million0.01% of portfolio
-
Pictet Asset Management Holding Sa Carouge, V83.58MShares$108 Million0.1% of portfolio
-
Geode Capital Management, LLC Boston, MA3.21MShares$96.5 Million0.01% of portfolio
About TG THERAPEUTICS, INC.
- Ticker TGTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 145,274,000
- Market Cap $4.37B
- Description
- TG Therapeutics, Inc., a commercial stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its therapeutic product candidates include Ublituximab, an investigational glycoengineered monoclonal antibody for the treatment of B-cell non-hod...